Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of New Drugs
1003-3734
2009 Issue 17
Efficacy of fixed vs.free combination of enalapril-folic acid tablet in controlling elevated plasma homocysteine in patients with H-type hypertension
sun ning-ling1; qin xian-hui2; li jian-ping3; guan de-ming4; ge jun-bo5; hu jian6; wang yan-ni7; zhang fu-min8; tang hai-qin9; fu jia10; huo yong3 (1department of cardiology; people s hospital of peking university; beijing 100044; china; 2 institute for biomedicine; anhui medical university; hefei 230032; china; 3 department of cardiology; first hospital of peking university; beijing 100034; china; 4 first clinical medical college of harbin medical university; harbin 150001; china; 5 zhongshan hospital fudan university; shanghai 200032; china; 6 first affiliated hospital of china medical university; shenyang 110001; china; 7 first affiliated hospital of the school of medicine; xi an jiaotong university; xi an 710061; china; 8 first affiliated hospital of nanjing medical university; nanjing 210029; china; 9 department of geriatric cardiology; first affiliated hospital of anhui medical university; hefei 230022; china; 10 department of neurology; first affiliated hospital of anhui medical university; hefei 230022; china)
..............page:1635-1640
Nasal toxicity of breviscapine nasal spray in rats
shi sen-lin1; zhang han-qing2; zhang xiao-dong1; wu jin-jin1; xu lian-ying3; shen wei1; dai wen-yun1(1 college of pharmaceutical science; zhejiang chinese medical university; hangzhou 310053; china; 2 center hospital of jinhua; jinhua 321000; china; 3 college of chinese pharmaceutical science; shanghai chinese medical university; shanghai 201203; china)
..............page:1658-1663
Innovation strategy for rationale and clinical significance of a new combination of drugs: enalapril maleate and folic acid tablets
chen guang-liang1; huo yong2; li jiang-ping2; liu li-sheng3; xu xi-ping1; 4(1 anhui medical university biomedical institute; hefei 230032; china; 2 peking university first hospital; department of cardiology; beijing 100034; china; 3 fuwai cardiology hospital; beijing 100037; 4 shenzhen university biomedical institute; shenzhen 518060; china)
..............page:1590-1593,1604
Protective effect of gingkgo biloba leave extract(EGb761) against DPPH free radi cal-induced myocardial damage in isolated rat hearts
li nian-sheng1; he li-mei1; yu ke-nan2; fan ruo-hao2; xie yuan-yuan2; jiang de-jian1(1 department of pharmacology; school of pharmaceutical sciences; central south university; 2 clinical medicine; xiang-ya medical school; central south university; changsha 410078; china)
..............page:1677-1681
International development and research of new medicines for cardiovascular diseases and related diseases
du hai-zhou; liu gui-ling; liu na; l ting(medical library of the chinese pla; beijing 100039; china)
..............page:1605-1613,1622
Effects of heparin and domestic bivalirudin on coagulation during percutaneous coronary intervention
pan chun-mei; xiang ding-cheng; gong zhi-hua; wen yan-fei; gu xiao-long; he jian-xin(guangzhou general hospital of guangzhou command; guangzhou 510010; china)
..............page:1646-1648
Advances in hypertension and anti-hypertensive therapies in elderly population
hu da-yi1; guo yi-fang2(1 department of cardiology; peking university people s hospital; beijing 100044; china; 2 cardiology division in geriatric institute; hebei provincial people s hospital; shijiazhuang 050051; china)
..............page:1614-1617
Advance in the research and clinical application of new anticoagulants
xiong chang-ming(pulmonary vascular disease center; cardiovascular institute and fuwai hospital; cams and pumc; beijing 100037; china)
..............page:1618-1622
Signal mechanism of Salvia miltiorrhiza Bunge on the inhibition of HK-2 cells adhesion to neutrophils induced by hypoxia/reoxygenation in asphyxia neonate
lei xiao-ping1; dong wen-bin1; li meng-ni1; li qing-ping1; long han-an2; deng cun-liang3; wang ming-yong3(1 department of newborn medicine of the affiliated hospital; 2 department of pathology; 3 laboratory of infection and immunity of the affiliated hospital; luzhou medical college; luzhou; sichuan 646000; china)
..............page:1667-1671
Relative bioavailability and bioequivalence of famciclovir tablets in healthy volunteers
xu xue-gu1; jiang hai-yan; zhang xiu-hua2; hu guo-xin1; dai zong-shun3(1 department of pharmacology; wenzhou medical college; wenzhou 325000; china; 2 the first affiliated hospital of wenzhou medical college; wenzhou 325027; china; 3 institute of clinical pharmacology; tongji medical college of huazhong university of science and technology; wuhan 430030; china)
..............page:1649-1652,1681
Research and Development of Glorb goes in new time
kemal malik(head of bsp head of global development and board member)
..............page:1595-1596
Vasodilatation effect of salidroside on isolated thoracic aorta and its related mechanism
zhang yong; yan tian-hua; ma ying; wang qiu-juan; guo qing-long(department of physiology; china pharmaceutical university; nanjing 210009; china)
..............page:1672-1676
Effect of a single dose of rosuvastatin administration on peripheral blood cells gene expression in Chinese volunteers
hua cong-xiao1; 2; liu yu-qing2; li yi-shi2; liu hong2; xu li2(1 center for drug evaluation; state food and drug administration; beijing 100038; china; 2 peking union medical college; chinese academy of medical sciences; key laboratory of clinical trialresearch in cardiovascular drugs; ministry of health; fuwai hospital; beijing 100037; china)
..............page:1653-1657,1688
WINDOW OF NEW DRUGS
..............page:1585-1586
Research and development of new drugs,the ways of Bayer Schering Pharma
andreas busch(head of bsp global drug discovery and board member)
..............page:1597-1601
Effects of ginsenoside Rg_2 on cerebral circulation and brain edema
tian jian-ming1; liu jie2; li hao1; ye jin-mei1; li long-yun1(1 academy of traditinoal chinese medicine science of jilin province; changchun 130021; china; 2 jilin university preclinical medicine college; changchun 130021; china)
..............page:1664-1666
Advance in research of rosiglitazone
yang wen-ying(china-japan friendship hospital; beijing 100029; china)
..............page:1623-1624,1634
Efficacy and safety supervision in a hypertensive patient combined with hyperlipidemia
zhou ying1; li xi-xi2; cui yi-min1(1 department of pharmacy; the first hospital; peking university; beijing 100034; china; 2 pharmacy administration commission; chinese hospital association; beijing 100035; china)
..............page:1682-1684
Progress in the study of the inhibitors of cholesteryl ester transfer protein
zhu rong-fang; guo chang-bin; zhang liang-liang(department of chemistry; capital normal university; beijing 100048; china)
..............page:1625-1630,1640
Chief problems in modification study on manufacturing process of drug substances
he wu(center for drug evaluation; state food and drug administration; beijing 100038; china)
..............page:1602-1604
Bioequivalence of rosiglitazone tartrate tables and rosiglitazone maleate tables in healthy volunteers
sun pei-hong1; zhao xia1; liu yu-wang1; zhong da-fang2; wang wen-sheng3; sun bing-hui1; zhou ying1 cui yi-min1(1 peking university first hospical; beijing 100034; china; 2 shengyang pharmaceutical university; shenyang 110016; china; 3 shandong lukang pharmaceutical co.ltd.; jining 272021; china)
..............page:1641-1645
Progress in researches for compound Danshen Dropping Pill in treating altitude hypoxia
zhang xue-feng(high altitude disease research center of people s hospital; germud 816000; china)
..............page:1631-1634
Analysis for the uses of cardiovascular drugs in 22 hospitals in Nanjing city during 2005-2007
zou ying1; feng lin1; dai hui-zhen2(1 the first affiliated hospital of nanjing medical university; nanjing 210029; china; 2 research institute for medicine information of jiangsu province; nanjing 210004; china)
..............page:1685-1688
Dabigatran etexilate,a novel oral anticoagulant
huang sai-jie; xu jia-jun(department of pharmacy; renji hospital; school of medical; shanghai jiaotong university; shanghai 200127; china)
..............page:1587-1589,1596